Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | FITC-LNP@DOX, fluorescein isothiocyanate-labeled lipid nanoparticles loaded with doxorubicin |
| Catalog Number | R-C-10ZT |
| Alias | Fluorescein labeled lipid nanoparticles loaded with doxorubicin |
| Appearance | solid or powder |
| Molecular Formula | N/A |
| Solubility | Soluble in organic solvents |
| Storage | -20°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 year |
| Shipping Condition | low temperature transport |
| Application | drug delivery system |
| Specification | 10mg:Inquiry 25mg:Inquiry 50mg:Inquiry |
| Description | FITC-LNP@DOX is a highly innovative compound drug preparation consisting of fluorescein isothiocyanate (FITC)-labeled lipid nanoparticles (LNP) encapsulating doxorubicin (DOX). Lipid nanoparticles have unique advantages as a drug carrier. Its structure is similar to that of a cell membrane, which gives FITC-LNP@DOX good biocompatibility and can effectively reduce the immunogenicity and harmfulness in the organism. At the same time, it exhibits high drug loading capacity for both hydrophilic and hydrophobic drugs and can stably encapsulate doxorubicin. As a commonly used fluorescent marker, FITC has a maximum excitation wavelength of approximately 495nm. Under excitation at this wavelength, it emits green fluorescence of approximately 520nm. With this characteristic, FITC-LNP@DOX can be sensitively detected and accurately tracked under fluorescence microscopes, flow cytometers and other equipment, making it easy to grasp its distribution and transport path inside and outside the organism in real time. FITC-LNP@DOX combines the advantages of the three and has great potential in the field of tumor treatment research. On the one hand, the fluorescent tracer of FITC can be used to monitor the enrichment sites and metabolic processes of doxorubicin in the body, providing a basis for optimizing dosing regimens; on the other hand, lipid nanoparticles can achieve tumor-targeted delivery through surface modification, increase the concentration of doxorubicin in tumor tissues, enhance the anti-cancer effect, and reduce damage to normal tissues. |